Quest Diagnostics announced appointment of Michael Cole as vice president of health plans. He was most recently national vice president, employer and individual markets, leading a business segment representing 7.6 million covered members.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
142.9 USD | +1.78% |
|
+1.97% | +3.87% |
Jul. 10 | Quest Diagnostics to Buy OhioHealth's Outreach Lab Services Business | MT |
Jul. 10 | Citigroup Upgrades Quest Diagnostics to Buy From Neutral, Adjusts Price Target to $165 From $145 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.87% | 15.6B | |
+17.41% | 82.59B | |
-26.49% | 72.22B | |
-1.34% | 26.41B | |
+4.17% | 17.69B | |
-9.60% | 16.89B | |
+77.14% | 13.7B | |
+76.21% | 12.77B | |
-25.96% | 12.76B | |
+33.92% | 12.22B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Appoints Michael Cole as Vice President of Health Plans